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Background: An attempt to find a prediction method of death risk in patients affected by acute mediastinitis.
There is not such a tool described in available literature for that serious disease.
Methods: The study comprised 44 consecutive cases of acute mediastinitis. General anamnesis and biochemical
data were included. Factor analysis was used to extract the risk characteristic for the patients. The most valuable
results were obtained for 8 parameters which were selected for further statistical analysis (all collected during few
hours after admission). Three factors reached Eigenvalue >1. Clinical explanations of these combined statistical
factors are: Factor1 - proteinic status (serum total protein, albumin, and hemoglobin level), Factor2 - inflammatory
status (white blood cells, CRP, procalcitonin), and Factor3 - general risk (age, number of coexisting diseases).
Threshold values of prediction factors were estimated by means of statistical analysis (factor analysis, Statgraphics
Centurion XVI).
Results: The final prediction result for the patients is constructed as simultaneous evaluation of all factor scores.
High probability of death should be predicted if factor 1 value decreases with simultaneous increase of factors 2
and 3. The diagnostic power of the proposed method was revealed to be high [sensitivity =90%, specificity =64%],
for Factor1 [SNC = 87%, SPC = 79%]; for Factor2 [SNC = 87%, SPC = 50%] and for Factor3 [SNC= 73%, SPC = 71%].
Conclusion: The proposed prediction method seems a useful emergency signal during acute mediastinitis control
in affected patients.Introduction
Severe sepsis is still a major cause of postoperative mor-
bidity and mortality after surgery in patients with acute
mediastinitis (AM). The disease is characterized by rapid
and severe course and poor prognosis despite under-
taken on time aggressive surgical management and sup-
portive treatment in the intensive care conditions. The
cause of the failure of the treatment is complex. Local
anatomical conditions favor the infection spread in me-
diastinal anatomical loose tissues and the systemic reac-
tion to infection [1]. An association is emphasized
between the increase in mortality and the delay in surgi-
cal intervention [1-4]. The etiology of AM does not re-
main insignificant. The best chance of survival have the
patients previously healthy without earlier mediastinal
pathologies in whom infection develops as a result of* Correspondence: jablonski_s@vp.pl
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distribution, and reproduction in any mediuminjury or as a complication related to endoscopic diag-
nostic procedures [5-7]. If the disease develops in a pa-
tient with previous history of diseases, especially of
carcinoma or as the result of complications related to
thoracosurgical or cardiosurgical procedures, the death
risk increases [8-10]. It should be expected that a num-
ber of factors can affect the final prognosis e.g. age, eti-
ology, delay in diagnosis, the type of surgical procedure,
the kind and number of coexisting diseases, the type of a
pathogen, postoperative complications and others.
The management in this severe disease could facilitate
categorizing patients into appropriate risk groups in
order to undertake the most optimal treatment strategy
for the developing severe sepsis. Working out a simple
prognostic scale on the basis of the data obtained from
the medical history, clinical examination, diagnostic im-
aging and preliminary biochemical investigations can be
one of the useful solutions. Similar prognostic scales are
applied in other diseases such as e.g. acute pancreatitis:
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Table 1 Aetiology and surgical procedures in patients
with acute mediastinitis
AETIOLOGY Number Procedure Death
Iatrogenic (19)































Oesophageal perforation 3 PR-3 0




Boerhaave syndrome 1 PR-1 1
Burn of oesophagus with
perforation
1 ESPH-1 0




Dental abscess 4 DCUM- 2
CRD+MDT-2
1
Retropharyngeal abscess 3 DCUM- 2
CRD+MDV- 1
1
















Legends of surgical procedures:
- EX: exclusion
- PR: primary repair
- ESPH: oesophagectomy
- MDT: mediastinal drainage by thoracotomy
- MDV: mediastinal drainage by videothoracoscopy
- MDS: mediastinal drainage by sternotomy
- TD: T-tube drainage
- CRD: cervical drainage
- PN: pneumonectomy
- DCUM: drainage of cervix and upper mediastinum
- RVM: revirage and mediastinal drainage
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cation of Severe Acute Pancreatitis [11-13]. Scales trying
to determine the prognosis for severely sick patients have
also been created e.g.: Nutritional Risk Index (NRI)
[14,15] and Prognostic Inflammatory and Nutritional
Index(PINI) [16].
To date no method has been available for the evalu-
ation of the probability of recovery if a patient is affected
by acute mediastinitis.
Therefore, we attempt to find a clinically useful pre-
operative method of predicting the prognosis for patients
with AM on the basis of clinical examination and simple
laboratory investigations.
Material and methods
In the years 1998–2010, at the Department of Thoracic
Surgery, General and Oncological Surgery of the Medical
University of Lodz, there were treated 44 consecutive
patients with AM. The study group comprised the
patients fulfilling modified criteria of mediastinitis diag-
nosis worked out by Esterra et al. [17], which in the ori-
ginal version were related to descending necrotizing
mediastinitis: (1) clinical manifestation of severe infec-
tion; (2) demonstration of AM etiological factors; (3)
characteristic radiological picture of mediastanitis; (4)
isolation of the pathogen in microbiological cultures
from the mediastinal area; (5) intraoperative or postmor-
tem documentation of mediastinitis. Exponents of sepsis
in the form of: fever, tachycardia, hyperventilation and
leucocytosis were observed in all patients.
The study was given an approval by the institutional
Ethical Review Committee (ERC).
The age of the patients was from 19 to 83 years, mean
age 52.5 years (median 54.5). There were 31 men, mean
age 50,9 years (median 55) and 13 women, mean age
56.4 years (median 58). Majority of them were referred
to our department after earlier treatment in other cen-
ters which had an impact on the delay in diagnosis and
on appropriate surgical treatment.
The time of hospitalization was on the average about
3 weeks (23.84 ± 11.96 days, median 21.5). All patients
were operated, 14 patients died. The total death rate was
31.82% (38.7% in male and 15.4% in female group).
The etiology of AM was extremely differentiated
(Table 1). Iatrogenic complications were the most fre-
quent cause of mediastinal infection. They were found in
19 patients (43.2%) and associated with esophageal and
tracheal surgeries or with injuries to these organs during
endoscopy or intubation. Non-iatrogenic esophageal and
tracheal injuries were the cause of AM in 11 patients
(25%). This group also included perforations caused by a
foreign body. Descending AM was detected in 9 patients
(20.4%). In 5 patients (11.4%) AM resulted from a spon-
taneous perforation of advanced esophageal cancer or
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etiology).
All patients underwent surgery. The time from the es-
tablishment of the diagnosis of AM to the introduction
of surgical treatment ranged from 2 h to 11 days, mean
1.62 days (±1.86), median (1.0). Surgical strategy was
determined individually dependently on the etiology,
delay from the diagnosis establishment, local conditions
and the patient’s general condition. The surgery, first of
all, aimed at controlling the infection source and at limit-
ing local inflammation by means of a wide cervical and/
or mediastinal drainage through various surgical
approaches. A detailed list of the performed surgical pro-
cedures and mortality rate of AM patients is presented
in Table 1.
The following clinical risk features were evaluated: age,
gender, etiology of coexisting diseases, delay in surgical
treatment, isolated pathogens, type of surgical procedure,
the number and type of postoperative complications.
Then, the association between mortality rate and selected
biochemical risk factors was investigated analyzing the
following parameters: hemoglobin level, hematocrit, red
blood cell count, leucocytosis, platelet count, serum so-
dium and potassium level, values of the inflammation
markers: C-reactive protein (CRP) and procalcitonin
(PCT) in preoperative period and on day 3 postopera-
tively. General and biochemical data were included
(Table 2). The factors for which in statistical analysis no
association was found with the prognosis were excluded
from further studies.
Statistical analysis
Statistical method of the factor analysis was used to
extract the risk aspects for the patients (Statgraphics
Centurion XVI, StatPoint Technologies, Inc. Warrenton,
USA). Then, the clinical value of the extracted factors
was evaluated by ANOVA, where the treatment outcome
was investigated. Variances were checked by Levene’s test.
As p value for this statistics was less than 0.05, Kruskal-
Wallis Test was applied to check the significance.
Finally, the number of significant preoperative factors
for the prognosis was reduced to 8 parameters which
were grouped into 3 prognostic factors named respect-
ively: proteinic status, inflammatory status and general
status arranged dependently on their statistical power.Table 2 Data included into this paper from treated patients a
Age Coex_diseas HGB W
Average 52,5455 1,97727 11,5677 15
Standard deviation 13,7595 1,42223 2,14823 5,
Legend: Coex_diseas – coexisting diseases; HGB – level of hemoglobin in venous bl
surgical treatment immediately after department admission [x106/μl]; CRP_pre – C-r
department admission (mg/l); PCT_pre – procalcitonin in serum collected before su
level of total serum proteins (g/l); Albumins – albumin level in serum (g/l).All utilized parameters can be collected in a simple way
during examination of the patient directly after admis-
sion to the ward and after laboratory investigations
(within 2–3 hours).
The first factor explained as “proteinic status” informs
about the initial state of protein metabolism. This par-
ameter is composed of results of laboratory tests of
blood: serum protein, albumin and hemoglobin (HGB)
level.
The second factor “inflammatory status” allows to esti-
mate the patient’s septic state on the basis of three la-
boratory parameters determined prior to the treatment:
white blood cell count (WBC_pre), CRP value (CRP_pre),
PCT value (PCT_pre).
The third factor of the prediction schema “general risk”
focuses on the evaluation of the patient’s clinical state
and includes only two important parameters: age (Age)
and the number of coexisting diseases (Coex_disease).
Coefficients of sensitivity (SNC) and specificity (SPC)
were calculated for the extracted factors to check the
prediction power of the suggested method. The proposed
method is designed for the prediction of recovery. Thus,
the result of the test is positive (P) if the test predicts the
recovery, and negative (N) if the test does not predict
the recovery but i.e. “death”. Respectively, the result of
the test is true (T) if the test predicts recovery when the
observed result is “recovery”, and the result of the test is
false (F) if the test does not predict the recovery. There-
fore: TP-patient recovered and predicted as “recovery”,
TN-patient died and predicted as “death”, FP-patient died
but predicted as “recovery”, and FN - patient recovered
but predicted as “death”. Basing on the above definitions,
the suggested sensitivity and specificity coefficients equa-
tions are:
Sensitivity coefficient: SNC ¼ TPTPþFN  100%
Specificity coefficient: SNC ¼ TPTPþFN  100%
Results
Three factors have been extracted as statistically
requested (Eigenvalue> 1), they are presented in Table 3.
Together they account for over 69% of the variability in
the original data. The initial communality estimates have
been set to assume that all of the variability in the data is
due to common factors (principal components method).ffected with acute mediastinitis
BC_pre CRP_pre PCT_pre Proteins Albumins
,2432 202,891 2,93409 57,3864 31,6773
14417 50,1198 3,92167 7,35118 3,90652
ood (g/dl) WBC_pre – white blood cell count in venous blood collected before
eactive protein collected before surgical treatment immediately after
rgical treatment immediately after department admission (ng/ml); Proteins –









1 3,31109 41,389 41,389 1,0
2 1,16325 14,541 55,929 1,0
3 1,04991 13,124 69,053 1,0
4 0,754858 9,436 78,489 1,0
5 0,682004 8,525 87,014 1,0
6 0,540662 6,758 93,772 1,0
7 0,358296 4,479 98,251 1,0
8 0,139929 1,749 100,000 1,0
Note: for 3 factors the Eigenvalue is >1.
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simplify the clinical explanation of the factors, the rota-
tion of the matrix was performed. Table 4 shows the
parameters for equations, which estimate the common
factors after rotation has been performed. Basing on
those scores in the next statistical step, the factor
(rotated) equations were constructed:
Factor1 ¼ 0; 712131HGBþ 0; 854481Proteins
0; 131796Coexdiseas þ 0; 00534419WBCpre
0; 141942Ageþ 0; 908303Albumins
0; 651832CRPpre  0; 560482PCTpre
Factor2 ¼ 0; 152337HGB 0; 0461529Proteins
0; 0604516Coexdiseas þ 0; 914729WBCpre
þ0; 263779Age 0; 0949298Albumins
þ0; 514794CRPpre þ 0; 371643PCTpre
Factor3 ¼ 0; 243032HGB 0; 0418942Proteins
þ0; 863627Coexdiseas þ 0; 108861WBCpre
þ0; 685527Age 0; 167625Albumins
þ0; 0364827CRPpre þ 0; 141625PCTpre
where the values of the variables (x) in the equations are
standardized by subtracting their means (μ) and dividing
by their standard deviations (σ). It also shows theTable 4 Factor loading matrix after varimax rotation









PCT_pre −0,560482 0,371643estimated communalities, which can be interpreted as
estimating the proportion of the variability in each vari-
able attributable to the extracted factors.
Visual presentation of extracted factors is shown in
Figure 1. Final factor scores calculated for all factors
included into this study, together with easy explanation
of their meanings are presented in Table 5.
There are three separate groups: HGB+Proteins +
Albumim, WBC_pre +CRP_pre + PCT_pre, and Age +
Coex_diseas.
According to the above, clinical meaning of the factors
was established. Factor1 (F1) is “proteinic status” of the
patient, Factor2 (F2) – “inflammatory status”, and Fac-
tor3 (F3) – “general risk” understood as the composite of
age and number of coexisting diseases. The statistics of
these factors in the presented clinical series is shown in
Table 6.
Finally, clinical verification was done by checking the
extracted factors value in our series of patients concern-
ing the outcome of the treatment as recovery or death
(Table 7). ANOVA results are presented in Figure 2 for
F1 (F = 21.78, p< 0.0001; Levene`s test = 4.0978, p< 0.05;
Kruskal-Wallis test = 11.9168, p< 0.001), for F2 (F = 8.45,
p< 0.01; Levene`s test = 8.9967, p< 0.01; Kruskal-Wallis
test = 4.9168, p< 0.05), and for F3 (F = 14.18, p< 0.001;
Levene`s test = 0.0001, p = 0.9929).
The final number of extracted factors was three. Fur-
thermore, the coefficients of sensitivity and specificity
were calculated for each factor (for F1: SNC=87%, SPC=
79%; for F2: SNC=87%, SPC= 50%; for F3: SNC=73%,
SPC= 71%), and next the prevalence test classification
(TP, TN, FP, FN) was performed to establish the whole
prognostic power of the method: SNC=90%, SPC= 64%.
The schema of the proposed prediction method appli-
cation is presented in Figure 3.
The probability of recovery increases when F1 is higher.
In other words, when “proteinic status” is worse the risk
of death is higher. As far as the “inflammatory status”
(F2) is concerned, in our series, lower scores are observed













Figure 1 Plot of final factor loading after matrix rotation.
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of “proteinic status” is analyzed, the value dividing recov-
ery outcome from death is approximately −1,4 (F1). It
should be understood as high probability of the patient’s
recovery if the score is higher than −1.4. In case of “in-
flammatory status” the caesura is located around +1.0
(F2). The prediction of survival is for patients with the
score lower than +1.0. Respectively, “general risk” (F3)
score lower than +0.4 is a prediction of recovery outcome
(as presented in tab.5). The predictable result based on
F1 is most of all in compliance with the observed result
of the treatment (only 7 variances/44 results). The var-
iances result from the application of 3 factors. It should
be known that if 8 parameters are subject of analysis, the
whole explanation of variability is possible with 8 factors.
The same is visible in density traces (Figure 2) where full
strict dichotomic separation of recovery from death out-
come subpopulations is impossible. That kind of mutually
penetrating subpopulations is often observed in biological
sciences.
Discussion
Early recognition of septic complications, information
about sepsis severity and thus, the ability to predict the
prognosis can have a significant impact on the treatment
strategy in AM. Access to such data can be of import-
ance in establishing the urgency and type of surgical
intervention, monitoring in postoperative period, neces-
sity for repair, the kind of antibiotic-therapy and support-
ive treatment. In medicine, numerous prognostic scales
have been created allowing to assess the prognosis in
selected pathological states. However, in available litera-
ture we have not found a scale related to acute mediasti-
nitis. Most probably it results from rare prevalence of
this disease and difficulty in gathering appropriately richmaterial within one medical centre. The proposed prog-
nostic method, based on the evaluation of 8 simple and
easy to obtain parameters compiled in the form of 3 fac-
tors, allows dichotomic categorization of patients into 2
groups as regards the predicted prognosis: survival or
death. When the calculated values of individual factors
are combined, it is easy to distinguish within first few
hours of hospitalization the patients whose prognosis is
worse than that of the others. Obviously, the selection of
proper parameters for the estimation of the predicted
prognosis in the course of AM can be the subject of
discussion.
In practice the first information about the patient’s
general condition is obtained during taking the history
data. At this stage we can obtain the data regarding
patient’s age and coexisting diseases which in the pro-
posed prognostic scale are important for calculating fac-
tor 3 values. In critically ill patients with sepsis, older age
and coexisting diseases are associated with poor progno-
sis [18-20]. There are several prognostic scales consider-
ing the effectof coexisting diseases on the prognosis. The
best known are: Charlson Comorbidity Index (CCI),
Davies (Stokes) score and Index of Coexisting Diseases
(ICED). They are widely applied in the patients dialyzed
due to renal failure [21-24]. Charlson scale, which esti-
mates similar parameters as our scale but it is based on
different methodology, is used most frequently. It takes
into account 19 coexisting diseases which are assigned
with a score. CCI includes age as one of the evaluated
elements and the age scores are counted according to
the following scheme: 1 score for each decade over
40 years of age. The total score enables to predict the
prognosis [25]. It was demonstrated in C-Y Wang’s study
that higher value of CCI (>2) in patients treated surgi-
cally due to stage I of lung cancer was associated with
Table 5 Factor scores











1 Death −8,61293 1,97822 2,03692 TN
2 Recovery −1,89787 1,01016 0,60735 FN
3 Death −5,67083 1,17312 3,18046 TN
4 Recovery 2,96689 0,0611059 −1,30167 TP
5 Death −4,61678 0,759947 1,84367 TN
6 Death −3,58174 3,35379 2,15131 TN
7 Recovery 1,24868 −0,0408765 0,219901 TP
8 Recovery −2,55507 0,0101163 −0,12325 FN
9 Recovery 0,858724 0,588775 0,151806 TP
10 Recovery −1,95238 0,0573994 0,216068 FN
11 Recovery 3,64292 −0,704072 −0,684944 TP
12 Recovery 2,6163 −1,34394 −2,25436 TP
13 Death −4,19034 4,84986 0,915751 TN
14 Recovery 1,82354 0,0636333 −1,26561 TP
15 Recovery 3,03511 1,12721 −0,649727 TP
16 Recovery 3,37817 −1,38079 −2,2192 TP
17 Recovery 0,580244 −0,316079 −1,61708 TP
18 Death −1,56375 −2,27389 −0,389642 TN
19 Death −1,78795 −0,0187813 −0,789484 TN
20 Recovery 0,57392 1,00331 −0,714067 TP
21 Recovery 2,86891 −0,0531427 −1,05936 TP
22 Recovery 0,343636 0,293051 0,970888 TP
23 Recovery 1,14208 −0,965971 −1,6126 TP
24 Recovery 5,51418 −1,06023 −3,28449 TP
25 Death −3,25473 1,29683 1,1493 TN
26 Death −2,12645 2,29104 0,529981 TN
27 Recovery 2,29387 0,0084471 1,6481 TP
28 Death 0,907509 −0,6706 3,7267 FP
29 Recovery 1,29283 −1,69442 0,299441 TP
30 Recovery 3,45795 −1,35408 −2,1628 TP
31 Death 2,96653 −1,47445 −0,86775 FP
32 Recovery 0,0323576 −1,55881 0,509574 TP
33 Recovery 1,0745 0,26778 0,334441 TP
34 Death −2,52481 2,36734 1,19426 TN
35 Recovery 1,32141 1,05543 0,824733 TP
36 Recovery 1,29592 −1,62119 −2,8627 TP
37 Death −5,05654 0,832591 1,11692 TN
38 Recovery 2,11607 −0,960466 −0,634111 TP
39 Recovery −1,4526 0,511999 1,41191 FN
40 Recovery −0,871523 −1,93215 −0,779669 TP
41 Death 3,87668 −2,0661 −0,280317 FP
42 Recovery −1,30349 −0,759654 0,880723 TP
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Table 5 Factor scores (Continued)
43 Recovery 1,76721 −1,49925 −1,44593 TP
44 Recovery 0,0236466 −1,21219 1,07856 TP
This table shows the factor scores (prognostic) for each patient from our data file (observation). *− level of dichotomic division of subpopulation: recovery and
death, see cross of the lines in density traces (Figure 2). Bold-lack of agreement between prediction and observation. Classification result: TP-true positive, TN-true
negative, FP-false positive, FN-false negative.
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lower number of comorbidities; CCI< 2 [26]. The pro-
posed by us prognostic scale is different because the data
on the general state (F3) are only one of three estimated
elements. If after substituting the data concerning age
and coexisting diseases for the given formula for “F3” we
obtain the value<+0.4, there increases the chance for
the patient’s survival. F3 is important for the whole scale
but according to our calculations it has a lower diagnostic
value compared to the remaining two factors (SNC=73%,
SPC= 71%). Anticipating the questions why there were
not taken into account such obvious clinical risk factors
as: etiology, delay in diagnosis or the type of pathogen,
we want to explain that the introduction of these data, to
our surprise, led in consequence to the weakening of the
algorithm diagnostic value. It seems that additional para-
meters can act the opposite way in the whole pool. Pre-
sumably, the factor analysis eliminated less reliable
variables leaving those which presented the highest pre-
dictive power in the proposed algorithm. For instance,
the delay in diagnosis and the time of the introduction of
the surgical treatment are not unequivocal parameters. It
is worth emphasizing that majority of the patients were
hospitalized earlier on other wards, where initially no
proper diagnosis was established. Furthermore, they were
then subjected to surgical procedures the effect of which
could sometimes deteriorate their condition and some-
times improve it partially. Similar remarks concern the
bacterial flora which changed in the course of the treat-
ment and finally its distribution was the effect of coinci-
dence, antibiotic therapy and/or infection. It wasTable 6 Final statistics of factor scores







Count 44 44 44
Average 9,55 × 10-8 5,11 × 10-7 1,36 × 10-7
Median 0,72 −0,005 0,18
Standard deviation 2,98 1,50 1,52
Minimum −8,61 −2,27 −3,28
Maximum 5,51 4,85 3,73
Range 14,13 7,12 7,01
Standardized skewness −1,88 2,64 0,26
Standardized kurtosis 0,45 1,94 −0,01impossible to classify such internally unstable parameters
by the method of factor analysis and attempts of their in-
clusion into the algorithm had a negative effect on the ac-
curacy of the prediction.
Laboratory investigations are important elements of
the proposed algorithm. The determination of other risk
factors, found in already mentioned 2 factors: “proteinic
status” and “inflammatory status” using 6 simple bio-
chemical tests, supplements our prognostic method. F1
determines the initial state of the patient’s protein me-
tabolism on the basisof 3 parameters: total protein, albu-
min and HGB level. Malnutrition and hypoproteinemia
are distinctly associated with increased death rate due to
infection and neoplastic disease [27,28]. An objective esti-
mation of malnutrition and protein metabolism is usually
difficult, it is based on clinical observation, determination
of BMI and biochemical investigations [29]. Among bio-
chemical markers albumin level is most frequently used
in malnutrition assessment. Hypoalbuminemia is asso-
ciated with malnutrition and the decrease of protein level
because liver reduces albumin production in favor of
more important plasma proteins [16]. In 1988 Busby
et al., first described the Nutritional Risk Index (NRI) to
score the severity of postoperative complications [14,15].
It combines two nutritional indicators (albumin and
weight loss), which are strictly correlated with higher
morbidity and mortality risk in the population of elderly
patients [30]. The need of determining ideal body weight,
which is difficult in elderly or critically ill patients, is one
of the limitations of this scale. Thus, it became necessary
to find a formula enabling to calculate ideal body weight,Table 7 Final statistics of subgroups (factor scores)
Factor1 Factor2 Factor3
Proteinic status Inflammatory status General risk
death recovery death recovery death recovery
Count 14 30 14 30 14 30
Average −2,52 1,17 0,89 −0,41 1,11 −0,52
Median −2,89 1,27 1,00 −0,18 1,13 −0,64
Standard deviation 3,36 1,89 2,06 0,93 1,41 1,30
Minimum −8,61 −2,56 −2,27 −1,93 −0,87 −3,28
Maximum 3,88 5,51 4,85 1,13 3,73 1,65
Range 12,49 8,07 7,12 3,06 4,59 4,93
Stnd. skewness 0,64 −0,19 0,16 0,18 0,41 −0,70
Stnd. kurtosis 0,20 −0,18 −0,28 −1,38 −0,43 −0,79
Figure 2 Comparison of Proteinic status (Factor 1), Inflammatory status (Factor 2), and General risk (factor 3) in subpopulation of
recovery and lethal outcome of acute mediastinitis. The difference is statistically significant.
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Geriatric Nutritional Risk Index (GNRI) [31]. Basing on
the performed analysis we have demonstrated that there
is also a need for inclusion of the hemoglobin level intothe prognostic scale. It was included into the markers es-
timating “proteinic status”. The presence of anemia is a
known factor affecting poor prognosis, particularly in
combination with other diseases [32,33]. The studies of
Figure 3 Schema of the application of the recovery prediction method.
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increases with the decrease of HGB concentration and
even benign forms of anemia can be associated with the
increase of the death risk [34]. The advantage of the sug-
gested prognostic method is the determination of protein
metabolism in simpler way than in NRI or GNRI basing
only on biochemical tests which is of importance in
patients in critical condition. The obtained high diagnos-
tic value for “proteinic status”, corresponding with the
final prognosis (SNC=87%, SPC= 79%) should be . If the
value of F1 calculated on the basis of the formula is lower
than −1.4, it means a high death risk for the patient.
We are convinced that in the case of infectious dis-
eases limitation to the assessment of protein metabolism,
age and co-existing diseases is not sufficient for the pre-
diction of the prognosis. It seems natural to extend the
prognostic scale including biochemical markers of in-
flammation. White blood cell count (WBC) is the oldest
widely used marker. It should be reminded that WBC
value is one of the criteria of SIRS and sepsis diagnosis
[35]. Fever in combination with elevated WBC count is a
quick and cheap way of infection diagnosis but its low
diagnostic value is its basic limitation [36]. This param-
eter in combination with other inflammatory markers
still has a wide clinical application both in the diagnosis
and monitoring of the results of the treatment. CRP
remains one of the most important classic markers forinflammation. It is included into sensitive but little spe-
cific acute phase proteins, the level of which increases in
inflammation and malignancy [37,38]. It has been con-
firmed that initial CRP values were directly associated
with total mortality rate in neoplastic disease [39]. How-
ever, Matson et al. paid attention to the fact that “normal”
plasma CRP level in critically ill patients is rarely the
same as in healthy population [40]. The post-mortem
studies demonstrated that in patients with cachexia
related to malignant carcinoma, in the case of extensive
tumor necrosis, significant deviations were observed in
the behavior of acute phase proteins [41]. That is why in
these cases the determination of CRP alone can appear to
be insufficient in the monitoring of inflammation. PCT is
a biochemical marker extremely useful in the diagnosis
and differentiation of severe infections and septic compli-
cations [42-44]. The increase of PCT concentration
induced by bacterial toxins (with preserved insensitivity
to other pro-inflammatory stimuli) and close relation be-
tween serum PCT concentration and infection severity
are the most important properties of this marker [45,46].
Taking into account the above mentioned properties we
have included serum PCT concentration into F2 evalu-
ation. We think that simultaneous determination of three
biochemical markers will enable more precise and more
objective assessment of “inflammatory status” eliminating
errors resulting from heterogeneity of the investigated
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Among the prognostic scales using inflammatory state
markers we have not found any similar to ours. Our scale
is unique due to the combination of biochemical data of
inflammation with simultaneous assessment of the
patient’s general condition and protein metabolism.
Ingenbleek and Carpentier Prognostic Inflammatory and
Nutritional Index (PINI) deserves attention [16]. The
scale is based on the evaluation of 4 parameters: 2 mar-
kers of malnutrition: albumin and prealbumin, and 2
markers of inflammatory state: CRP and α1acid glycopro-
tein (AAG). This scoring system may predict morbidity
or mortality in hospitalized patients [24]. The normal
PINI level in healthy population is <1. The value of PINI
(>1) is associated with poor prognosis [16,47]. PINI has
been found to be a reliable indicator of both nutritional
status and prognosis in trauma, burns and infection
[48,49] and lately in cancer [50]. PINI is slightly similar to
the scale proposed by us, as it considers 2 of 3 analyzed
groups of risk factors. In our investigations we did not
determine AAG, which is not a marker commonly used
in clinical practice in our country, and prealbumin due to
its susceptibility to nutrition inhibition, which always
occurs in the course of the treatment of AM patients.
Other authors also confirmed that nutritional state can
affect inflammatory response in patients with advanced
carcinoma and the results of PINI prognostic scale
[51,52]. Wunder et al. presented an interesting attempt of
working out an independent indicator of early prediction
of death in sepsis [53]. The authors, analyzing 33 patients
with sepsis of different etiology, noticed that the devia-
tions of the values of PCT and Acute Physiology and
Chronic Health Evaluation (APACHE II) were correlated
with poor prognosis. Novotny et al. carried out similar
studies on a larger group of 160 patients with sepsis
resulting from peritonitis or mediastinitis after an anasto-
motic leak and perforation of a hollow organ [54]. It
should be noted that the clinical material presented in
this study was to a great extent similar to our material.
The authors, owing to combination of both indicators
and calculations with the use of binary logistic regression
analysis, were able to identify the groups of high and low
death risk. In a multivariate analysis, both PCT and
APACHE III score were identified as independent, early
predictive indicators of sepsis lethality. While 71% of the
high-risk patients died of sepsis, 77% of patients assigned
to the low-risk group survived the septic complication
(sensitivity 71%, specificity 77%) [54]. To compare, the
diagnostic value for “inflammatory status” in the sug-
gested method obtained higher sensitivity (87%) but
lower specificity (50%). Poor prognosis should be sus-
pected in patients whose value of F2 calculated from the
formula is <1.0.High death rate in the course of AM points to the
need of further studies. Rare prevalence of the disease
and high differentiation of the material within one med-
ical centre are the limitations. Thus, introduction of mul-
ticentre register of the patients should be taken into
consideration. A detailed analysis of the investigated
cases in a large representative group of patients can have
an influence on the determination of risk factors and on
the improvement of the prognosis in patients treated
surgically due to AM.Conclusion
We do hope that the proposed prognostic method has a
chance to be introduced into the clinical practice which
can contribute to the modification of the treatment of
patients with AM. It is based on mathematical assess-
ment of own material and devoid of subjective interpret-
ation. Its most important advantages are: inclusion into
the assessment of 2 simple clinical data and 6 biochem-
ical tests which can be obtained within first 2–3 hours
after the patient’s admission to hospital (duration of la-
boratory investigations), low costs and simple interpret-
ation of the results. We think that the construction of
the method, based on the evaluation of 3 groups of risk
factors determining inflammatory, proteinic and general
status, will be less sensitive to difficult to foresee devia-
tions of the values of biochemical markers associated
with the impact of factors such as: malnutrition, bacterio-
logical etiology, comorbidities, surgical complications and
others. To simplify the calculations, the scale can be pre-
pared in a form of automatic electronic “calculator”
which provides a ready result after entering appropriate
data. The result proving poor prognosis should induce to
more aggressive surgical treatment and to modification of
antibiotic-therapy and supportive treatment.Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.
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